Wai Yuen Tong Medicine Holdings Limited

897 BMG9421Y2332

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 04:09:00 2024-05-03 am EDT			5-day change	1st Jan Change
0.23 ^HKD	0.00%		0.00%	-42.50%

Apr. 02	Wai Yuen Tong Medicine Holdings Limited commences an Equity Buyback Plan for 117,110,288 shares, representing 10% of its issued share capital, under the authorization approved on August 22, 2023.	CI
Mar. 28	Wai Yuen Tong Medicine Holdings Limited Announces Changes of Company Secretary, with Effect from 1 April 2024	CI

Tranche Update on Wai Yuen Tong Medicine Holdings Limited's Equity Buyback Plan announced on September 1, 2022.

December 21, 2023 at 03:52 am EST

From January 1, 2023 to August 22, 2023, the company has repurchased 33,540,000 shares, representing 2.78% for HKD 14.73 million. With this, the company has completed the repurchase of 60,540,000 shares, representing 4.98% for HKD 24.69 million under the buyback announced on September 1, 2022.

Latest news about Wai Yuen Tong Medicine Holdings Limited

Wai Yuen Tong Medicine Holdings Limited commences an Equity Buyback Plan for 117,110,288 shares, representing 10% of its issued share capital, under the authorization approved on August 22, 2023.	Apr. 02	CI
Wai Yuen Tong Medicine Holdings Limited Announces Changes of Company Secretary, with Effect from 1 April 2024	Mar. 28	CI
Wai Yuen Tong Medicine Unit to Sell Properties in Hong Kong	Mar. 04	MT
Wai Yuen Tong Medicine Plans Special Dividend of Wang On, China Agri-Products Shares; Shares Up 7%	Jan. 26	MT
Wai Yuen Tong Medicine Holdings Limited agreed to Spin-Off Wang On Group Limited.	Jan. 24	CI
Wai Yuen Tong to Buy Shop Space in Hong Kong	Jan. 23	MT
Wai Yuen Tong Medicine Shareholders to Vote Jan. 30 on Granting of Loan Facility to Wang On	Jan. 10	MT
Tranche Update on Wai Yuen Tong Medicine Holdings Limited's Equity Buyback Plan announced on September 1, 2022.	Dec. 21	CI
Wai Yuen Tong Medicine to Extend Revolving Loan Facility to Wang On	Dec. 18	MT
Wai Yuen Tong Medicine Holdings Limited Announces Change of Independent Non-Executive Directors and Change in Compositions of Board Committees	Dec. 08	CI
Wai Yuen Tong Medicine Returns to Profit in Fiscal H1	Nov. 28	MT
Wai Yuen Tong Medicine Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2023	Nov. 28	CI
Wai Yuen Tong Medicine Subsidiary Sells Stake in Owner of Leased Shops	Nov. 21	MT
Wai Yuen Tong Medicine to Return to Profit in Fiscal H1	Nov. 14	MT
Wai Yuen Tong Medicine Holdings Limited Provides Consolidated Earnings Guidance for the Six Months Ended 30 September 2023	Nov. 13	CI
Wai Yuen Tong Medicine Holdings Limited's Equity Buyback announced on September 1, 2022, has expired with 60,540,000 shares, representing 4.98% for HKD 24.69 million.	23-08-21	CI
Wai Yuen Tong Medicines' Fiscal Year 2023 Loss Narrows	23-06-29	MT
Tranche Update on Wai Yuen Tong Medicine Holdings Limited's Equity Buyback Plan announced on September 1, 2022.	23-06-28	CI
Wai Yuen Tong Medicine Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-06-28	CI
Lei Wa entered completed the acquisition of Billion Good Investment Limited from Wai Yuen Tong Medicine Holdings Limited and Wang On Limited.	23-06-18	CI
Wai Yuen Tong Medicine to Narrow Full-Year Loss	23-06-09	MT
Wai Yuen Tong Medicine Holdings Limited Provides Earnings Guidance for the Financial Year Ended 31 March 2023	23-06-09	CI
Wai Yuen Tong Medicine, Wang On Sell Hong Kong Factory for HK$71 Million	23-02-07	MT
Lei Wa entered into the Provisional Agreement to acquire Billion Good Investment Limited from Wai Yuen Tong Medicine Holdings Limited and Wang On Limited for HKD 71 million.	23-02-05	CI
Wai Yuen Tong Medicine Sells Hong Kong Property for HK$49 Million	23-01-09	MT

Chart Wai Yuen Tong Medicine Holdings Limited

Duration

Period

Chart Wai Yuen Tong Medicine Holdings Limited

More charts

Company Profile

Wai Yuen Tong Medicine Holdings Limited is a Hong Kong-based investment holding company principally engaged in the production and sales of pharmaceutical products. The Company operates through three segments. Production and Sale of Chinese Pharmaceutical and Health Food Products segment is mainly engaged in the manufacture, processing and retailing of traditional Chinese medicine in China and Hong Kong. Its products include Chinese medicines under the brand Wai Yuen Tong, as well as products manufactured with traditional prescriptions. Production and Sale of Western Pharmaceutical and Health Food Products segment is engaged in the processing and sales of Western pharmaceutical products and personal care products under the brands Madame Pearlâs and Pearlâs. Property Investment segment is engaged in the investment in commercial properties for rental income.

Sector

Pharmaceuticals

Calendar

2024-06-24 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Alternative Medicine

	1st Jan change	Capi.
WAI YUEN TONG MEDICINE HOLDINGS LIMITED	-42.50%	33.13M
DONG-E-E-JIAO CO.,LTD.	+39.33%	6.11B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-18.38%	4.35B
TASLY PHARMACEUTICAL GROUP CO., LTD	-9.17%	3.19B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+3.98%	3.15B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-3.41%	2.51B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+48.74%	1.98B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-4.82%	1.74B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-1.24%	1.63B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-8.96%	1.6B